Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-21

FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company. Insulin lispro is used to improve glycemic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HUMALOG MIX50/50 KWIKPEN (Insulin lispro)

Snippet

SUPPL AP for HUMALOG MIX50/50 KWIKPEN (INSULIN LISPRO)